Log In
BCIQ
Print this Print this
 

ceralifimod (ONO-4641)

  Manage Alerts
Collapse Summary General Information
Company Ono Pharmaceutical Co. Ltd.
DescriptionSphingosine 1-phosphate (S1P) receptor agonist
Molecular Target Sphingosine 1-phosphate (S1P) receptor
Mechanism of ActionSphingosine 1-phosphate (S1P) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS); Treat relapsing-remitting multiple sclerosis (RRMS)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$19.5M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/10/2011

Undisclosed

$19.5M

Undisclosed

Get a free BioCentury trial today